Dr. Aled Edwards is founder and chief executive of the Structural Genomics Consortium (SGC), a research organization celebrated for being a pioneer of open science, particularly as it applies to protein science, chemical biology and drug discovery. Dr. Edwards leads the six SGC laboratories from the SGC headquarters in Canada.

Dr. Edwards is a professor at the University of Toronto and adjunct professor at McGill University. He has published over 200 papers and his teams have contributed over 4,500 structures to the Protein Data Bank as of 2021. Dr. Edwards has also founded many companies, including Affinium Pharmaceuticals, which developed a novel antibiotic currently in late-stage clinical trials, and M4K Pharma, the first pharmaceutical company formed explicitly to invent new, and affordably-priced, medicines for pediatric cancers.